Electrocardiographic abnormalities and psychotropic polypharmacy in schizophrenia and schizoaffective disorders

Srinivasan Tirupati1, Sachal Gulati2

  • 1Psychiatric Rehabilitation Service, Hunter New England Mental Health, Morisset, NSW, Australia; and School of Public Health and Medicine, Faculty of Health, The University of Newcastle, Callaghan, NSW, Australia.

Insights

Sudden cardiac death is a risk for schizophrenia patients. Many patients have electrocardiogram (ECG) abnormalities, not just prolonged QTc, indicating potential arrhythmia risks needing evaluation.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Sudden cardiac death (SCD) is a major cause of mortality in individuals with schizophrenia and schizoaffective disorders.
  • Cardiac arrhythmias are a known cause of SCD, and electrocardiogram (ECG) abnormalities can predict these arrhythmias.
  • Antipsychotic drug use has been linked to ECG abnormalities.

Purpose of the Study:

  • To examine the types and frequency of ECG abnormalities (ECG-Abs) in patients with schizophrenia and schizoaffective disorder.
  • To investigate the association of ECG-Abs with demographic factors and psychotropic drug prescriptions.

Main Methods:

  • A chart audit was conducted on 169 patients in a long-stay inpatient unit.
  • Statistical analyses included chi-square test, Fisher's Exact test, independent two-sample t-test, Pearson's correlation, and one-way ANOVA.
  • ECG abnormalities were assessed in relation to demographic details and psychotropic medication.

Main Results:

  • Over half of the patients (52.1%) exhibited at least one ECG abnormality.
  • A significant portion (20.7%) had two or more ECG abnormalities.
  • The use of multiple antipsychotics, with or without other psychotropic drugs, did not show a significant association with the presence or number of ECG abnormalities.

Conclusions:

  • A substantial number of patients with schizophrenia and schizoaffective disorder present with ECG abnormalities beyond prolonged QTc interval, potentially predisposing them to cardiac arrhythmias.
  • These ECG abnormalities are not exclusive to patients on psychotropic polypharmacy.
  • Comprehensive ECG evaluation is recommended for all patients to identify arrhythmia risk, considering a range of electrical abnormalities.
Abstract

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
525
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
255
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
116
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.1K
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
366
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
198